References
- Jungbluth H, Wallgren-Pettersson C, Laporte J. Centronuclear (myotubular) myopathy. Orphanet J Rare Dis 2008;3:26. https://doi.org/10.1186/1750-1172-3-26
- Jungbluth H, Gautel M. Pathogenic mechanisms in centronuclear myopathies. Front Aging Neurosci 2014;6:339.
- Echaniz-Laguna A, Nicot AS, Carre S, Franques J, Tranchant C, Dondaine N, et al. Subtle central and peripheral nervous system abnormalities in a family with centronuclear myopathy and a novel dynamin 2 gene mutation. Neuromuscul Disord 2007;17:955-9. https://doi.org/10.1016/j.nmd.2007.06.467
- Bohm J, Biancalana V, Dechene ET, Bitoun M, Pierson CR, Schaefer E, et al. Mutation spectrum in the large GTPase dynamin 2, and genotype-phenotype correlation in autosomal dominant centronuclear myopathy. Hum Mutat 2012;33:949-59. https://doi.org/10.1002/humu.22067
- Bitoun M, Maugenre S, Jeannet PY, Lacene E, Ferrer X, Laforet P, et al. Mutations in dynamin 2 cause dominant centronuclear myopathy. Nat Genet 2005;37:1207-9. https://doi.org/10.1038/ng1657
- Catteruccia M, Fattori F, Codemo V, Ruggiero L, Maggi L, Tasca G, et al. Centronuclear myopathy related to dynamin 2 mutations: clinical, morphological, muscle imaging and genetic features of an Italian cohort. Neuromuscul Disord 2013;23:229-38. https://doi.org/10.1016/j.nmd.2012.12.009
- Susman RD, Quijano-Roy S, Yang N, Webster R, Clarke NF, Dowling J, et al. Expanding the clinical, pathological and MRI phenotype of DNM2-related centronuclear myopathy. Neuromuscul Disord 2010;20:229-37. https://doi.org/10.1016/j.nmd.2010.02.016
- Hanisch F, Muller T, Dietz A, Bitoun M, Kress W, Weis J, et al. Phenotype variability and histopathological findings in centronuclear myopathy due to DNM2 mutations. J Neurol 2011;258:1085-90. https://doi.org/10.1007/s00415-010-5889-5
- Chen T, Pu C, Wang Q, Liu J, Mao Y, Shi Q. Clinical, pathological, and genetic features of dynamin-2-related centronuclear myopathy in China. Neurol Sci 2015;36:735-41. https://doi.org/10.1007/s10072-014-2028-6
- Mori-Yoshimura M, Okuma A, Oya Y, Fujimura-Kiyono C, Nakajima H, Matsuura K, et al. Clinicopathological features of centronuclear myopathy in Japanese populations harboring mutations in dynamin 2. Clin Neurol Neurosurg 2012;114:678-83. https://doi.org/10.1016/j.clineuro.2011.10.040
- Park YE, Choi YC, Bae JS, Lee CH, Kim HS, Shin JH, et al. Clinical and pathological features of Korean patients with DNM2-related centronuclear myopathy. J Clin Neurol 2014;10:24-31. https://doi.org/10.3988/jcn.2014.10.1.24
- Fischer D, Herasse M, Bitoun M, Barragan-Campos HM, Chiras J, Laforet P, et al. Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy. Brain 2006;129:1463-9. https://doi.org/10.1093/brain/awl071